Channel 4's upcoming documentary The Great ADHD Myth? has ignited controversy, prompting leading charity ADHD UK to publish an open letter condemning the program's framing. The letter argues that posing a question mark over ADHD's validity creates harm and stigma, asserting: 'ADHD is not scientifically controversial. It is recognised by the World Health Organisation, the NHS, NICE, and every major medical body on Earth.' The charity further warns, 'This is not a parlour debate. People die,' citing higher suicide rates among those with ADHD.
Scientific Consensus and Neurobiological Evidence
The documentary, airing this evening, seeks to determine whether ADHD is a genuine neurodevelopmental disorder or a social construct. However, medical evidence strongly supports the former. Dr Claudia Aymerich, consultant psychiatrist at Berkeley, tells Metro: 'Evidence shows a genetic and neurobiological basis for ADHD, especially concerning brain mechanisms responsible for attention, executive function and impulse control.' A 2017 study found that up to 83% of children with symptoms had 'abnormalities' in brain structure, and neuroimaging studies reveal differences in adult ADHD brains, including a smaller prefrontal cortex.
The NHS classifies ADHD as a neurodevelopmental disorder, defined by the American Psychiatric Association as conditions affecting brain development and function. This places ADHD alongside autism and Tourette's syndrome, reinforcing its legitimacy.
Environmental Factors and Diagnosis Rates
While environmental factors like ultra-processed food and screen time can worsen symptoms, they do not cause ADHD. Hester Grainger, a neurodiversity consultant and ADHD coach, explains: 'Things like ultra-processed food and too much screen time can affect how we feel and function. Sometimes ADHD traits can feel harder to manage because of them, but they don't cause ADHD. I grew up in the 1970s without a smartphone, and I still have ADHD.'
Diagnosis rates have surged, with a UCL study showing a twenty-fold increase between 2000 and 2018, and an almost fifty-fold rise in prescriptions for men aged 18-29. However, this does not mean 'everyone' has ADHD; the condition still affects only 2% to 6% of the world's population. The increase reflects better recognition, not a rise in prevalence.
Misconceptions About Diagnosis and Demographics
The documentary features Dr Max Pemberton, who pays £1,200 to obtain an ADHD diagnosis despite not believing he has it. However, as psychologist Dr Andrea Pickering notes, symptoms like distractibility are relatable, but 'the key difference is that for someone with ADHD, these symptoms are persistent, pervasive and significantly impact their ability to function in daily life.' Assessments also consider speech patterns, body language, and family history.
The stereotype of ADHD as a condition affecting only hyperactive boys is false. Women often experience internal hyperactivity, leading to underdiagnosis. The ADHD Foundation estimates that 50-70% of the 1,000,000 women in the UK with ADHD are undiagnosed. Hester Grainger adds that women can have combined ADHD with internal hyperactivity, where 'inside their brain it's non-stop.'
Medication Safety and Historical Context
ADHD medications are often compared to cocaine, but experts refute this. Dr Samantha Hiew, founder of ADHD Girls, says: 'No, absolutely not. The right medication can really prop someone's life up.' Dr Manish Rao, consultant child and adolescent psychiatrist, emphasises that medications are rigorously tested, and 'the risks of untreated ADHD – including higher rates of depression, substance misuse, and accidental injury – far outweigh the monitored risks of medication.'
ADHD is not a new condition; it was formally named in 1968 as 'hyperkinetic reaction of childhood,' with descriptions dating back to the 1700s. Hester Grainger concludes: 'People had ADHD long before we had the language, awareness, or diagnostic criteria we have today. They didn't suddenly have ADHD, we just got better at recognising it.'
